|
Dr. Robert Murray obtained his PhD in Chemical Engineering from the University of Virginia and his BS (Magna Cum Laude) and MS both in Chemical Engineering from Drexel University in 1999 and 2001, respectively. His thesis titled, Pharmacokinetics of Trans Sodium Crocetinate and the Treatment of Two Hypoxic States: Hemorrhagic Shock and Acute Lung Injury highlights his depth of knowledge of the Company�s lead drug candidate, TSC. As Research Project Manager, Dr. Murray is responsible for the operation of the Company�s internal laboratory and performing exploratory work with the Company�s technology. | 